PT678018E - Conjugados moleculares ionicos de poliesteres biodegradaveis e de polipeptidos bioactivos - Google Patents
Conjugados moleculares ionicos de poliesteres biodegradaveis e de polipeptidos bioactivosInfo
- Publication number
- PT678018E PT678018E PT94906037T PT94906037T PT678018E PT 678018 E PT678018 E PT 678018E PT 94906037 T PT94906037 T PT 94906037T PT 94906037 T PT94906037 T PT 94906037T PT 678018 E PT678018 E PT 678018E
- Authority
- PT
- Portugal
- Prior art keywords
- biodegradable polyesters
- molecular conjugates
- bioactive polypeptides
- ionic molecular
- composition
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 230000000975 bioactive effect Effects 0.000 title abstract 2
- 229920000229 biodegradable polyester Polymers 0.000 title 1
- 239000004622 biodegradable polyester Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 229920000728 polyester Polymers 0.000 abstract 2
- 150000001412 amines Chemical class 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polyesters Or Polycarbonates (AREA)
- Medicinal Preparation (AREA)
- Biological Depolymerization Polymers (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE930005 | 1993-01-06 | ||
| CNB941085236A CN1163260C (zh) | 1993-01-06 | 1994-07-20 | 可生物降解聚酯和生物活性多肽的离子性分子轭合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT678018E true PT678018E (pt) | 2003-08-29 |
Family
ID=37075859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT94906037T PT678018E (pt) | 1993-01-06 | 1994-01-05 | Conjugados moleculares ionicos de poliesteres biodegradaveis e de polipeptidos bioactivos |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0678018B1 (pt) |
| JP (1) | JPH08505395A (pt) |
| CN (1) | CN1163260C (pt) |
| AT (1) | ATE236655T1 (pt) |
| AU (1) | AU680650B2 (pt) |
| CA (1) | CA2150574A1 (pt) |
| CZ (2) | CZ293378B6 (pt) |
| DE (1) | DE69432459T2 (pt) |
| DK (1) | DK0678018T3 (pt) |
| ES (1) | ES2196023T3 (pt) |
| FI (1) | FI114898B (pt) |
| HU (1) | HU220137B (pt) |
| NZ (1) | NZ261250A (pt) |
| PL (1) | PL174772B1 (pt) |
| PT (1) | PT678018E (pt) |
| RU (2) | RU2185393C2 (pt) |
| SG (1) | SG47043A1 (pt) |
| SK (1) | SK74495A3 (pt) |
| WO (1) | WO1994015587A2 (pt) |
| ZA (1) | ZA9477B (pt) |
Families Citing this family (79)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6221958B1 (en) * | 1993-01-06 | 2001-04-24 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| US6413539B1 (en) * | 1996-10-31 | 2002-07-02 | Poly-Med, Inc. | Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US6413536B1 (en) * | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
| US7833543B2 (en) | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
| US5955574A (en) | 1995-07-13 | 1999-09-21 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. | Analogs of parathyroid hormone |
| DE69731623D1 (de) * | 1996-04-23 | 2004-12-23 | Ipsen Mfg Ireland Ltd | Saure Polymilchsäure Polymere |
| IE960308A1 (en) | 1996-04-23 | 1997-11-05 | Kinerton Ltd | Sustained release ionic conjugate |
| AU750739B2 (en) * | 1996-04-23 | 2002-07-25 | Ipsen Manufacturing Ireland Limited | Methods for preparing biodegradable polyesters and derivatives thereof |
| US6264970B1 (en) | 1996-06-26 | 2001-07-24 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| US5968895A (en) * | 1996-12-11 | 1999-10-19 | Praecis Pharmaceuticals, Inc. | Pharmaceutical formulations for sustained drug delivery |
| AU779930B2 (en) * | 1996-12-11 | 2005-02-17 | Praecis Pharmaceuticals Incorporated | Pharmaceutical formulations for sustained drug delivery |
| US6126919A (en) | 1997-02-07 | 2000-10-03 | 3M Innovative Properties Company | Biocompatible compounds for pharmaceutical drug delivery systems |
| AR012448A1 (es) * | 1997-04-18 | 2000-10-18 | Ipsen Pharma Biotech | Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada |
| US6867181B1 (en) | 1997-06-02 | 2005-03-15 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| AR020650A1 (es) * | 1998-08-10 | 2002-05-22 | Poly Med Inc | Polimeros fosforilados y conjugados de los mismos |
| EP1348444B1 (en) * | 1999-08-18 | 2006-04-12 | Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. | Sustained release formulation of a peptide complexed with a polymer |
| IES990700A2 (en) * | 1999-08-18 | 2001-08-22 | Kinerton Ltd | Process to make a sustained release formulation |
| CZ2002333A3 (cs) * | 1999-08-18 | 2002-08-14 | Societe De Conseils De Recherches Et D'application | Sloučenina 1 obsahující sloučeninu A, farmaceutický prostředek a pouľití sloučeniny A pro výrobu léčiva pro léčení chorob |
| US7109166B1 (en) | 1999-08-18 | 2006-09-19 | Societe De Conseils De Recherches Et D'applications Scientifiques, Sas | Sustained release formulation of a peptide |
| HUP0300082A2 (en) | 2000-03-31 | 2003-05-28 | Paratek Pharmaceuticals | 7- and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline derivatives, process for their preparation and use and pharmaceutical compositions containing them |
| KR100452752B1 (ko) * | 2000-04-18 | 2004-10-12 | 주식회사 펩트론 | 단백질 함유 서방성 제제를 제조하는 방법 및 그 제제 |
| US6753015B2 (en) * | 2000-09-28 | 2004-06-22 | Chiron Corporation | Microparticle compositions and methods for the manufacture thereof |
| JP2004515533A (ja) * | 2000-12-14 | 2004-05-27 | アミリン・ファーマシューティカルズ，インコーポレイテッド | 代謝障害を治療するためのペプチドｙｙおよびペプチドｙｙアゴニスト |
| WO2002074247A2 (en) * | 2001-03-19 | 2002-09-26 | Praecis Pharmaceuticals Incorporated | Pharmaceutical formulations for sustained release |
| US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
| EP1556086A2 (en) * | 2002-10-31 | 2005-07-27 | Pfizer Products Inc. | Solid and semi-solid polymeric ionic conjugates |
| EP2959893A1 (en) | 2002-12-13 | 2015-12-30 | DURECT Corporation | Oral drug delivery system comprising high viscosity liquid carrier materials |
| US7166575B2 (en) | 2002-12-17 | 2007-01-23 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity |
| EA008829B1 (ru) | 2002-12-17 | 2007-08-31 | Нэстек Фармасьютикал Кампани Инк. | Композиции и способы для усовершенствованной доставки пептидов, связывающихся с y-рецепторами, которую осуществляют через слизистые оболочки, и способы лечения и предотвращения ожирения |
| US7229966B2 (en) | 2002-12-17 | 2007-06-12 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| US7186692B2 (en) | 2002-12-17 | 2007-03-06 | Nastech Pharmaceutical Company Inc. | Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| ATE365174T1 (de) | 2003-01-28 | 2007-07-15 | Microbia Inc | Zusammensetzungen zur behandlung von gastrointestinalen störungen |
| EP1633384B1 (en) | 2003-05-15 | 2012-03-14 | Trustees Of Tufts College | Stable analogs of glp-1 |
| EP1682537B1 (en) | 2003-11-05 | 2012-03-28 | SARcode Bioscience Inc. | Modulators of cellular adhesion |
| CA2581287C (en) | 2004-09-17 | 2015-08-25 | Durect Corporation | Sustained local anesthetic composition containing bupivacaine and saib |
| EP1871796A4 (en) | 2005-04-20 | 2009-01-14 | Auckland Uniservices Ltd | VESICULINE |
| CN101175488B (zh) | 2005-05-17 | 2012-04-18 | 萨可德公司 | 治疗眼病的组合物和方法 |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| US8318668B2 (en) | 2005-09-08 | 2012-11-27 | Trustees Of Tufts College | Stabilized GLP-1 analogs |
| HUE044391T2 (hu) | 2005-09-29 | 2019-10-28 | Ipsen Pharma | Készítmény gasztrointesztinális motilitászavar kezelésére |
| WO2007139589A1 (en) | 2006-05-26 | 2007-12-06 | Bristol-Myers Squibb Company | Sustained release glp-1 receptor modulators |
| EP2117521B1 (en) | 2006-11-03 | 2012-06-27 | Durect Corporation | Transdermal delivery systems comprising bupivacaine |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| CN103601792B (zh) | 2007-06-04 | 2016-06-29 | 协同医药品公司 | 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂 |
| LT2170390T (lt) | 2007-06-14 | 2019-01-10 | Biogen Ma Inc. | Natalizumabo antikūnų kompozicijos |
| TW200916113A (en) | 2007-08-08 | 2009-04-16 | Sod Conseils Rech Applic | Method for inhibiting inflammation and pro-inflammatory cytokine/chemokine expression using a ghrelin analogue |
| EP3167886B1 (en) | 2007-10-19 | 2020-08-05 | Novartis AG | Compositions and methods for treatment of macular edema |
| WO2009088414A2 (en) | 2007-12-06 | 2009-07-16 | Durect Corporation | Oral pharmaceutical dosage forms |
| WO2009139817A2 (en) | 2008-04-15 | 2009-11-19 | Sarcode Corporation | Crystalline pharmaceutical and methods of preparation and use thereof |
| AU2009256157B2 (en) | 2008-06-04 | 2014-12-18 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| KR101593285B1 (ko) | 2008-10-29 | 2016-02-11 | 아블린쓰 엔.브이. | 단일 도메인 항원 결합 분자의 제형 |
| US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
| US8378105B2 (en) | 2009-10-21 | 2013-02-19 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
| KR101224004B1 (ko) * | 2009-12-29 | 2013-01-22 | 주식회사 삼양바이오팜 | 단백질, 폴리펩타이드 또는 펩타이드 약물 전달용 고분자 및 그 제조방법, 및 단백질, 폴리펩타이드 또는 펩타이드 약물의 서방형 조성물 및 그 제조 방법 |
| CA2805572A1 (en) | 2010-07-16 | 2012-01-19 | Martin Hegen | Modified single domain antigen binding molecules and uses thereof |
| WO2012028496A1 (de) * | 2010-08-31 | 2012-03-08 | Basf Se | Verzweigte polyester auf basis von zitronensäure sowie deren herstellung und verwendung |
| BRPI1003424A2 (pt) * | 2010-09-08 | 2013-01-08 | Univ Rio De Janeiro | sistema polimÉtrico de confinamento de amilina humana e anÁlogos agonistas, processo e uso; processo de avaliaÇço funcional de amilina liberada |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| NZ608630A (en) | 2010-10-01 | 2015-03-27 | Biogen Idec Inc | Interferon-beta for use as monotherapy or in combination with other cancer therapies |
| JP6092849B2 (ja) | 2011-05-04 | 2017-03-08 | バランス セラピューティックス, インコーポレイテッドBalance Therapeutics, Inc. | ペンチレンテトラゾール誘導体 |
| PH12014500192A1 (en) * | 2011-07-22 | 2014-03-24 | Innocore Tech B V | Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds |
| HK1210782A1 (en) | 2012-07-25 | 2016-05-06 | Sarcode Bioscience Inc. | Lfa-1 inhibitor and polymorph thereof |
| US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
| WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| CA2905131A1 (en) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US9486494B2 (en) | 2013-03-15 | 2016-11-08 | Synergy Pharmaceuticals, Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| US20160129089A1 (en) | 2013-06-13 | 2016-05-12 | Antisense Therapeutics Ltd | Combination therapy |
| JP6661531B2 (ja) | 2013-10-10 | 2020-03-11 | シナジー ファーマシューティカルズ インコーポレイテッド | オピオイド誘発性機能障害の治療に有用なグアニル酸シクラーゼのアゴニスト |
| US9181427B2 (en) * | 2013-12-11 | 2015-11-10 | Ethicon, Inc. | Absorbable bimodal polymeric blend compositions, processing methods, and medical devices |
| JP6707537B2 (ja) * | 2014-11-14 | 2020-06-10 | レーム・ゲーエムベーハーＲｏｅｈｍ ＧｍｂＨ | 粒子の形の生体吸収性ポリエステルの製造方法 |
| US10653744B2 (en) | 2016-01-11 | 2020-05-19 | Bausch Health Ireland Limited | Formulations and methods for treating ulcerative colitis |
| KR102413459B1 (ko) | 2016-07-06 | 2022-06-24 | 듀렉트 코퍼레이션 | 약물 조성물, 장벽 층 및 약물 층을 갖는 경구 투여 형태 |
| TR201702016A2 (tr) | 2017-02-10 | 2018-08-27 | Tuerkiye Bilimsel Ve Teknolojik Arastirma Kurumu Tuebitak | Düşük mali̇yetli̇ yüksek moleküler ağirlikli ve yüksek çözünürlüğe sahi̇p poli̇gli̇koli̇k asi̇t sentezi̇ |
| KR20220140711A (ko) | 2020-01-13 | 2022-10-18 | 듀렉트 코퍼레이션 | 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법 |
| EP4277702A1 (en) | 2021-01-12 | 2023-11-22 | Durect Corporation | Sustained release drug delivery systems and related methods |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4356166A (en) * | 1978-12-08 | 1982-10-26 | University Of Utah | Time-release chemical delivery system |
| IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US4609707A (en) * | 1983-11-10 | 1986-09-02 | Genetic Systems Corporation | Synthesis of polymers containing integral antibodies |
| US5071909A (en) * | 1989-07-26 | 1991-12-10 | Millipore Corporation | Immobilization of proteins and peptides on insoluble supports |
| US5162505A (en) * | 1989-09-19 | 1992-11-10 | Centocor | Proteins modified with positively charged carriers and compositions prepared therefrom |
| CA2046830C (en) * | 1990-07-19 | 1999-12-14 | Patrick P. Deluca | Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer |
| GB9310030D0 (en) * | 1993-05-15 | 1993-06-30 | Scras | Dry processed particles and process for the preparation of the same |
-
1994
- 1994-01-05 AT AT94906037T patent/ATE236655T1/de not_active IP Right Cessation
- 1994-01-05 WO PCT/US1994/000148 patent/WO1994015587A2/en not_active Ceased
- 1994-01-05 CA CA002150574A patent/CA2150574A1/en not_active Abandoned
- 1994-01-05 NZ NZ261250A patent/NZ261250A/xx unknown
- 1994-01-05 AU AU59921/94A patent/AU680650B2/en not_active Ceased
- 1994-01-05 DK DK94906037T patent/DK0678018T3/da active
- 1994-01-05 SG SG1996004005A patent/SG47043A1/en unknown
- 1994-01-05 CZ CZ19951734A patent/CZ293378B6/cs not_active IP Right Cessation
- 1994-01-05 HU HU9502029A patent/HU220137B/hu not_active IP Right Cessation
- 1994-01-05 RU RU99122608/04A patent/RU2185393C2/ru not_active IP Right Cessation
- 1994-01-05 PL PL94309776A patent/PL174772B1/pl not_active IP Right Cessation
- 1994-01-05 RU RU95118395/14A patent/RU2146128C1/ru not_active IP Right Cessation
- 1994-01-05 DE DE69432459T patent/DE69432459T2/de not_active Expired - Fee Related
- 1994-01-05 CZ CZ20002050A patent/CZ293425B6/cs not_active IP Right Cessation
- 1994-01-05 EP EP94906037A patent/EP0678018B1/en not_active Expired - Lifetime
- 1994-01-05 ES ES94906037T patent/ES2196023T3/es not_active Expired - Lifetime
- 1994-01-05 SK SK744-95A patent/SK74495A3/sk unknown
- 1994-01-05 PT PT94906037T patent/PT678018E/pt unknown
- 1994-01-05 JP JP6516182A patent/JPH08505395A/ja active Pending
- 1994-01-06 ZA ZA9477A patent/ZA9477B/xx unknown
- 1994-07-20 CN CNB941085236A patent/CN1163260C/zh not_active Expired - Fee Related
-
1995
- 1995-07-05 FI FI953314A patent/FI114898B/fi active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AU5992194A (en) | 1994-08-15 |
| NZ261250A (en) | 1997-08-22 |
| SG47043A1 (en) | 1998-03-20 |
| FI953314L (fi) | 1995-07-05 |
| CZ293378B6 (cs) | 2004-04-14 |
| HUT73188A (en) | 1996-06-28 |
| ES2196023T3 (es) | 2003-12-16 |
| EP0678018A1 (en) | 1995-10-25 |
| FI953314A0 (fi) | 1995-07-05 |
| EP0678018A4 (en) | 1998-09-09 |
| HU9502029D0 (en) | 1995-09-28 |
| CZ173495A3 (en) | 1996-01-17 |
| DK0678018T3 (da) | 2003-04-28 |
| CN1163260C (zh) | 2004-08-25 |
| DE69432459D1 (de) | 2003-05-15 |
| WO1994015587A2 (en) | 1994-07-21 |
| ATE236655T1 (de) | 2003-04-15 |
| RU2185393C2 (ru) | 2002-07-20 |
| CZ293425B6 (cs) | 2004-04-14 |
| CA2150574A1 (en) | 1994-07-21 |
| RU2146128C1 (ru) | 2000-03-10 |
| WO1994015587A3 (en) | 1994-09-01 |
| CN1115252A (zh) | 1996-01-24 |
| DE69432459T2 (de) | 2003-11-27 |
| ZA9477B (en) | 1994-08-11 |
| JPH08505395A (ja) | 1996-06-11 |
| AU680650B2 (en) | 1997-08-07 |
| HU220137B (hu) | 2001-11-28 |
| SK74495A3 (en) | 1997-01-08 |
| PL309776A1 (en) | 1995-11-13 |
| EP0678018B1 (en) | 2003-04-09 |
| PL174772B1 (pl) | 1998-09-30 |
| FI114898B (fi) | 2005-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT678018E (pt) | Conjugados moleculares ionicos de poliesteres biodegradaveis e de polipeptidos bioactivos | |
| HK1040406A1 (zh) | 生物可分解聚酯與生物活性多肽之離子性分子共軛物 | |
| DE69434046D1 (de) | Nicht-antigene verzweigte Polymerconjugate | |
| BR9305660A (pt) | Filmes de polímero lactideo de fusao estável e processos para fabricaçao dos mesmos | |
| PL323735A1 (en) | Ionic molecular conjugates of n-acylated derivatives of poly92-amino-2-dezoxy-d-glucose) and polypeptides | |
| ATE177757T1 (de) | Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17 | |
| BR8008041A (pt) | Poliesteramidas de estrutura em boclo, estatistica ou alternada | |
| ES2193272T3 (es) | Conjugados peptidicos, su utilizacion como medicamento y composiciones que los contienen. | |
| ES2196187T3 (es) | Conjugados peptidicos derivados de las hormonas timicas, su utilizacion a titulo de medicamento y composiciones que los contienen. | |
| ITMI931325A0 (it) | Composizione farmaceutica ad attivita' analgesica | |
| DE69117085D1 (de) | Nylon-6 modifiziert mit Polyethylenglykoldiaminen von niedrigem Molekulargewicht | |
| IT1270961B (it) | Composizioni poliestere ad elevata viscosita' | |
| IL175808A0 (en) | Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides | |
| FI964730L (fi) | Taittuva pylväs | |
| ITRM920045A0 (it) | Composizioni farmaceutiche ad attivita' anti-aging. | |
| IT9022196A0 (it) | Film polimerico modificato caratterizzato da elevata barriera all'ossigeno | |
| IT1255989B (it) | Composizioni poliestere ad elevata velocita' di cristallizzazione. | |
| ITRM920044A1 (it) | Composizioni farmaceutiche ad attivita' anti-aging. | |
| ITRM920043A0 (it) | Composizioni farmaceutiche ad attivita' anti-aging. |